8 µm Chemotaxis Assays, 24-Well Format

8 µm Chemotaxis Assays, 24-Well Format
  • Fully quantify chemotaxis with no manual cell counting
  • Measure chemotaxis in less than 6 hours with most cell types
  • Membrane inserts are uncoated to allow use with any chemoattractant
  • Colorimetric or fluorometric detection

 

Frequently Asked Questions about this product

General FAQs about Chemotaxis Assays

Email To BuyerPrint this PageCopy Link
Ordering

Please contact your distributor for pricing.

CytoSelect™ 24-Well Cell Migration Assay, 8 μm
Catalog Number
CBA-100
Size
12 assays
Detection
Colorimetric
Manual/Data Sheet Download
SDS Download
Price
$505.00
CytoSelect™ 24-Well Cell Migration Assay, 8 μm
Catalog Number
CBA-101
Size
12 assays
Detection
Fluorometric
Manual/Data Sheet Download
SDS Download
Price
$505.00
CytoSelect™ 24-Well Cell Migration Assay, 8 μm
Catalog Number
CBA-100-5
Size
5 x 12 assays
Detection
Colorimetric
Manual/Data Sheet Download
SDS Download
Price
$2,290.00
CytoSelect™ 24-Well Cell Migration Assay, 8 μm
Catalog Number
CBA-101-5
Size
5 x 12 assays
Detection
Fluorometric
Manual/Data Sheet Download
SDS Download
Price
$2,290.00
Product Details

Chemotaxis describes the movement of cells toward or away from a chemical stimulus in their enviroment. Cell chemotaxis plays a pivotal role in the progression of cancer and other diseases.

CytoSelect™ Cell Migration Assays are ideal for determining the chemotactic properties of cells. The 8 µm pore size is suitable for most cell types including epithelial cells, fibroblasts, and cancer cell lines.

CytoSelect™ Chemotaxis Assay Principle. Migratory cells move through the polycarbonate membrane toward a chemoattractant underneath the membrane inserts.

Migration of Human Fibrosarcoma HT-1080 Cells. Cells were seeded at 30,000 cells per well of a 24-well plate and allowed to migrate toward 10% FBS for 4 hours in either the presence or absence of 2µM Cytochalasin D. Migratory cells on the bottom of the polycarbonate membrane were stained (top) and quantified in a fluorescence plate reader (bottom).

Recent Product Citations
  1. Yanagisawa, H. et al. (2026). Endothelial C-type natriuretic peptide/guanylyl cyclase-B signaling prevents pulmonary arterial hypertension. Nat Commun. 17(1):2331. doi: 10.1038/s41467-026-70139-2 (#CBA-101).
  2. Tomita, M. et al. (2026). Innate Immune Cell Infiltration Induced by Polatuzumab Vedotin Contributes to the Antitumor Effect in Mouse Models. EJHaem. 7(1):e70219. doi: 10.1002/jha2.70219 (#CBA-100).
  3. Hamadmad, S. et al. (2026). MIF inhibition attenuates proliferative vitreoretinopathy pathogenesis and protects the eye in preclinical model. Biomed Pharmacother. 195:118943. doi: 10.1016/j.biopha.2025.118943 (#CBA-100).
  4. Nahmias Blank, D. et al. (2025). Unraveling the Role of Metabolic Endotoxemia in Accelerating Breast Tumor Progression. Biomedicines. 13(8):1868. doi: 10.3390/biomedicines13081868 (#CBA-101).
  5. Alakija, F.B. & Mills, D.K. (2025). Fabrication and Characterization of a Stretchable Sodium Alginate Hydrogel Patch Combined with Silicon Nitride and Metalized Halloysite Nanotubes to Develop a Chronic Wound Healing Treatment. Int J Mol Sci. 26(4):1734. doi: 10.3390/ijms26041734.
  6. Shi, H. et al. (2025). Interleukin-1 receptor-associated kinase-1 is a therapeutic target for gastric cancer. Discov Oncol. 16(1):1882. doi: 10.1007/s12672-025-03658-x (#CBA-100).
  7. He, J. et al. (2025). The role of cell surface RNAs in hepatocellular carcinoma. Int J Biol Macromol. 330(Pt 3):147948. doi: 10.1016/j.ijbiomac.2025.147948 (#CBA-100).
  8. Khatiwada, P. et al. (2024). MDM2 regulates the stability of AR, AR-V7, and TM4SF3 proteins in prostate cancer. Endocr Oncol. 4(1):e230017. doi: 10.1530/EO-23-0017 (#CBA-101).
  9. Jakob, Y. et al. (2024). Suitability of Ex Vivo-Expanded Microtic Perichondrocytes for Auricular Reconstruction. Cells. 13(2):141. doi: 10.3390/cells13020141 (#CBA-101).
  10. Caratis, F. et al. (2024). The proton-sensing receptors TDAG8 and GPR4 are differentially expressed in human and mouse oligodendrocytes: Exploring their role in neuroinflammation and multiple sclerosis. PLoS One. 19(3):e0283060. doi: 10.1371/journal.pone.0283060 (#CBA-100).
  11. Kagawa, T. et al. (2024). New treatment strategies for uterine sarcoma using secreted frizzled‑related proteins. Exp Ther Med. 27(5):231. doi: 10.3892/etm.2024.12520 (#CBA-100).
  12. Choi, C.R. et al. (2024). Enhancing Human Cutaneous Wound Healing through Targeted Suppression of Large Conductance Ca2+-Activated K+ Channels. Int J Mol Sci. 25(2):803. doi: 10.3390/ijms25020803 (#CBA-100).
  13. Suwatthanarak, T. et al. (2023). A peptide binding to the tetraspanin CD9 reduces cancer metastasis. Biomater Adv. doi: 10.1016/j.bioadv.2023.213283 (#CBA-101).
  14. Young, K.M. et al. (2023). Correlating mechanical and gene expression data on the single cell level to investigate metastatic phenotypes. iScience. 26(4):106393. doi: 10.1016/j.isci.2023.106393 (#CBA-101).
  15. Park, J. et al. (2023). Fermented Lettuce Extract Containing Nitric Oxide Metabolites Attenuates Inflammatory Parameters in Model Mice and in Human Fibroblast-Like Synoviocytes. Nutrients. 15(5):1106. doi: 10.3390/nu15051106 (#CBA-100).
  16. Kano, J. et al. (2022). Roles of DKK3 in cellular adhesion, motility, and invasion through extracellular interaction with TGFBI. FEBS J. doi: 10.1111/febs.16529 (#CBA-100).
  17. Kim, E.Y. et al. (2022). 1,2,3,4,6-Penta-O-galloyl-β-D-glucose Inhibits CD44v3, a cancer stem cell marker, by regulating its transcription factor, in human pancreatic cancer cell line. Anim Cells Syst. 26(6):328-337. doi: 10.1080/19768354.2022.2152864 (#CBA-100).
  18. Ryu, J.H. et al. (2022). Exploring the Effects of 630 nm Wavelength of Light-Emitting Diode Irradiation on the Proliferation and Migration Ability of Human Biceps Tendon Fibroblast Cells. Clin Orthop Surg. doi: 10.4055/cios22132 (#CBA-100).
  19. Pinto, N. et al. (2022). Introduction and expression of PIK3CAE545K in a papillary thyroid cancer BRAFV600E cell line leads to a dedifferentiated aggressive phenotype. J Otolaryngol Head Neck Surg. 51(1):7. doi: 10.1186/s40463-022-00558-w (#CBA-100).
  20. Cao, J. et al. (2022). circKL inhibits the growth and metastasis of kidney cancer by sponging miR‑182‑5p and upregulating FBXW7. Oncol Rep. 47(4):75. doi: 10.3892/or.2022.8286 (#CBA-100).
  21. Kawasaki, M. et al. (2021). Cytoplasmic-only Expression of Maspin Predicts Poor Prognosis in Patients With Oral Squamous Cell Carcinoma. Anticancer Res. 41(9):4563-4570. doi: 10.21873/anticanres.15269 (#CBA-101).
  22. Moore, K.H. et al. (2021). Syncytialization alters the extracellular matrix and barrier function of placental trophoblasts. Am J Physiol Cell Physiol. doi: 10.1152/ajpcell.00177.2021 (#CBA-100).
  23. Pande, R. et al. (2021). Hsa-miR-605 regulates the proinflammatory chemokine CXCL5 in complex regional pain syndrome. Biomed Pharmacother. 140:111788. doi: 10.1016/j.biopha.2021.111788 (#CBA-101).
  24. Singh, S. et al. (2020). Endothelial-specific Loss of IFT88 Promotes Endothelial-to-Mesenchymal Transition and Exacerbates Bleomycin-induced Pulmonary Fibrosis. Sci Rep. 10(1):4466. doi: 10.1038/s41598-020-61292-9 (#CBA-101).
  25. Wang, S. et al. (2020). Tissue-specific angiogenic and invasive properties of human neonatal thymus and bone MSCs: Role of SLIT3-ROBO1. Stem Cells Transl Med. doi: 10.1002/sctm.19-0448 (#CBA-101).
  26. Khatiwada, P. et al. (2020). Androgen up-regulation of Twist1 gene expression is mediated by ETV1. PeerJ. 8:e8921. doi: 10.7717/peerj.8921 (#CBA-101).
  27. Tam, J. et al. (2019). Skin Microcolumns as a Source of Paracrine Signaling Factors. Adv Wound Care. doi: 10.1089/wound.2019.1045 (#CBA-101).
  28. Fledrich, R. et al. (2019). NRG1 type I dependent autoparacrine stimulation of Schwann cells in onion bulbs of peripheral neuropathies. Nat Commun. 10(1):1467. doi: 10.1038/s41467-019-09385-6 (#CBA-101).
  29. Orbay, H. et al. (2018). Fat Graft Safety after Oncologic Surgery: Addressing the Contradiction between In Vitro and Clinical Studies. Plast Reconstr Surg. 142(6):1489-1499. doi: 10.1097/PRS.0000000000004992 (#CBA-101).
  30. Bezhaeva, T. et al. (2018). Relaxin receptor deficiency promotes vascular inflammation and impairs outward remodeling in arteriovenous fistulas. FASEB J. fj201800437R. doi: 10.1096/fj.201800437R (#CBA-101).